ABOUT VOYAGEUR
Voyageur Pharmaceuticals Ltd. is a drug manufacturing company focused on radiographic contrast media products. Voyageur is developing barium and iodine generic radiographic drugs, for the healthcare market. Voyageur is unique, as it is sourcing its own main ingredients from its own mineral deposits. Voyageur is building a business model that will allow it to be a fully integrated company in the radiographic market place.
Near-term cash flow is expected to be achieved through third party pharmaceutical manufacturing, sourcing third party minerals, turn key manufacturing, bottling and distribution of barium and iodine radiographic pharmaceutical drugs for MRI, X-ray and CT scan applications.
By implementing our “From The Earth to The Bottle” strategy, Voyageur will have a competitive advantage, by having low ingredient costs for our pharmaceutical product line.
Frank Wright and Ralph Hesje Join Voyageur Board of Directors
PR Q2 2021 New Directors July 26 2021 [...]
Vertical Integration = High Growth
https://investorintel.com/markets/biotech-healthcare/biotech-intel/voyageur-pharmaceuticals-strategy-is-to-remove-the-middleman-and-supply-radiographic-contrast-media-direct-from-mine-to-the-x-ray-center/
Financed & Moving Forward
https://investorintel.com/investorintel-video/brent-willis-on-voyageur-pharmaceuticals-competitive-suite-of-barium-radiographic-contrast-media-products/
Alberta Veterinarian Laboratories Drug Establishment Licence
https://www.newswire.ca/news-releases/calgary-facility-receives-drug-establishment-license-836677526.html
Drug Supply Becoming Strategic Issue For North America
https://www.washingtonexaminer.com/policy/defense-national-security/play-dirty-chinese-official-threatens-us-medical-supplies-over-huawei-fight
Voyageur Summer Summary
Voyageur Summer Strategy